Anke Stroet
Ruhr University Bochum
11 Papers
147 Citations
Anke Stroet is an academic researcher from Ruhr University Bochum. The author has contributed to research in topics: JC virus & Multiple sclerosis. The author has an hindex of 6, co-authored 11 publications.
Chat about Author
Papers
Functional identification of pathogenic autoantibody responses in patients with multiple sclerosis
Christina Elliott,Maren Lindner,Ariel Arthur,Kathryn M. Brennan,Sven Jarius,John Hussey,Andrew T. Chan,Anke Stroet,Tomas Olsson,Hugh J. Willison,Hugh J. Willison,Susan C. Barnett,Edgar Meinl,Christopher Linington +13 more
TL;DR: This study identifies axopathic and/or demyelinating autoantibody responses in a subset of patients with multiple sclerosis, which underlines the mechanistic heterogeneity of multiple sclerosis and provides a rational explanation why some patients benefit from antibody depleting treatments.
146
Anti-JC virus antibodies in a large German natalizumab-treated multiple sclerosis cohort
Anne-Kathrin Trampe,Claudia Hemmelmann,Anke Stroet,Aiden Haghikia,Kerstin Hellwig,Heinz Wiendl,Susan Goelz,Andreas Ziegler,R. Gold,Andrew T. Chan +9 more
TL;DR: In this article, the authors investigated the rate of seropositivity of anti-JC virus (JCV) antibodies in a German multiple sclerosis (MS) cohort treated with natalizumab in the postmarketing setting and to assess anti-JCV serostatus in samples obtained before diagnosis of progressive multifocal leukoencephalopathy (PML).
130
Low vitamin D and elevated immunoreactivity against Epstein–Barr virus before first clinical manifestation of multiple sclerosis
Bernhard F. Décard,Nicolas von Ahsen,Thomas Grunwald,Frank Streit,Anke Stroet,Petra Niggemeier,Volkmar Schottstedt,Joachim Riggert,Ralf Gold,Andrew T. Chan +9 more
TL;DR: Low vitamin D and remote EBV infection and anti-EBV immunoreactivity in 25 individuals before the first clinical manifestation of MS may be associated with clinical MS breakthrough within 2–3 years.
50
Incidence of therapy-related acute leukaemia in mitoxantrone-treated multiple sclerosis patients in Germany
Anke Stroet,Claudia Hemmelmann,M Starck,Uwe K. Zettl,Jan Dörr,Friedemann Paul,P. Flachenecker,Vinzenz Fleischer,Frauke Zipp,Holger Nückel,Bernd C. Kieseier,Andreas Ziegler,Ralf Gold,Andrew T. Chan +13 more
TL;DR: A retrospective meta-analysis from six centres observed six cases of therapy-related acute leukaemia in mitoxantrone treatment in multiple sclerosis and regional differences in reported TRAL incidence may point to confounding cofactors such as administration protocols and cotreatments.
36
Reduced lung function in a chronic asthma model is associated with prolonged inflammation, but independent of peribronchial fibrosis.
TL;DR: Prolonged lung function changes after long term allergen challenges seem to develop and resolve independently of the persistent peribronchial fibrosis.